Elanco Animal Health is a drug manufacturers - specialty & generic business based in the US. Elanco Animal Health shares (ELAN) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $13.44 – a decrease of 4.27% over the previous week. Elanco Animal Health employs 9,300 staff and has a trailing 12-month revenue of around $4.5 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $13.44 |
|---|---|
| 52-week range | $11.40 - $18.80 |
| 50-day moving average | $13.87 |
| 200-day moving average | $14.93 |
| Wall St. target price | $17.84 |
| PE ratio | 34.2439 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.41 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $13.31 from 2024-11-19
| 1 week (2024-11-15) | -4.79% |
|---|---|
| 1 month (2024-10-22) | 5.13% |
| 3 months (2024-08-22) | -8.90% |
| 6 months (2024-05-22) | -21.38% |
| 1 year (2023-11-22) | 11.57% |
|---|---|
| 2 years (2022-11-22) | 7.17% |
| 3 years (2021-11-22) | 32.05 |
| 5 years (2019-11-22) | 26.79 |
Valuing Elanco Animal Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Elanco Animal Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Elanco Animal Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Elanco Animal Health shares trade at around 34x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Elanco Animal Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8448. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Elanco Animal Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Elanco Animal Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $875 million.
The EBITDA is a measure of a Elanco Animal Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $4.5 billion |
|---|---|
| Gross profit TTM | $2.5 billion |
| Return on assets TTM | 1.18% |
| Return on equity TTM | 3.24% |
| Profit margin | 4.6% |
| Book value | $13.20 |
| Market Capitalization | $6.9 billion |
TTM: trailing 12 months
We're not expecting Elanco Animal Health to pay a dividend over the next 12 months.
Over the last 12 months, Elanco Animal Health's shares have ranged in value from as little as $11.4 up to $18.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Elanco Animal Health's is 1.417. This would suggest that Elanco Animal Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. .
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.